Rapt Therapeutics Inc (RAPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Operating Expenses | 43,629 | 36,947 | 29,331 | 0 |
| Operating Income | -43,629 | -36,947 | -29,331 | N/A |
| Other Income | 1,292 | 800 | 216 | 0 |
| Pre-tax Income | -42,337 | -36,147 | -29,115 | 0 |
| Income Tax | 660 | N/A | N/A | N/A |
| Net Income Continuous | -42,997 | -36,147 | -29,115 | N/A |
| Net Income | $-42,997 | $-36,147 | $-29,115 | $N/A |
| EPS Basic Total Ops | -79.12 | -464.72 | -539.60 | N/A |
| EPS Basic Continuous Ops | -79.14 | -464.70 | -539.57 | N/A |
| EPS Diluted Total Ops | -79.12 | -464.72 | -539.60 | N/A |
| EPS Diluted Continuous Ops | -79.14 | -464.70 | -539.57 | N/A |
| EPS Diluted Before Non-Recurring Items | -79.12 | N/A | N/A | N/A |
| EBITDA(a) | $-42,299 | $-35,710 | $-27,947 | $N/A |